Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Dec;68(6):862-872.
doi: 10.1053/j.ajkd.2016.05.030. Epub 2016 Aug 28.

Risk of ESRD in the United States

Patrick Albertus  1 , Hal Morgenstern  2 , Bruce Robinson  3 , Rajiv Saran  4
Affiliations
Comparative Study

Risk of ESRD in the United States

Patrick Albertus et al. Am J Kidney Dis. 2016 Dec.

Abstract

Background: Although incidence rates of end-stage renal disease (ESRD) in the United States are reported routinely by the US Renal Data System (USRDS), risks (probabilities) are not reported. Short- and long-term risk estimates need to be updated and expanded to minority populations, including Native Americans, Asian/Pacific Islanders, and Hispanics.

Study design: Risk estimation from surveillance data in large populations using life-table methods. A competing-risks framework was applied by constructing a hypothetical cohort followed from birth to death.

Setting & participants: Total US population. Incidence and mortality rates of ESRD were obtained from the USRDS; all-cause mortality rates were obtained from CDC WONDER.

Predictors: Age, sex, race/ethnicity, and year.

Outcomes: 10-year to lifetime risks (cumulative incidence) of ESRD.

Results: Among males, lifetime risks of ESRD from birth using 2013 data were 3.1% (95% CI, 3.0%-3.1%) for non-Hispanic whites, 8.0% (95% CI, 7.9%-8.2%) for non-Hispanic blacks, 3.8% (95% CI, 3.4%-4.9%) for non-Hispanic Native Americans, 5.1% (95% CI, 4.8%-5.4%) for non-Hispanic Asians/Pacific Islanders, and 6.2% (95% CI, 6.1%-6.4%) for Hispanics. Among females, lifetime risks were 2.0% (95% CI, 2.0%-2.1%) for non-Hispanic whites, 6.8% (95% CI, 6.7%-6.9%) for non-Hispanic blacks, 3.6% (95% CI, 3.3%-4.2%) for non-Hispanic Native Americans, 3.8% (95% CI, 3.6%-4.0%) for non-Hispanic Asian/Pacific Islanders, and 4.3% (95% CI, 4.2%-4.5%) for Hispanics. Lifetime risk of ESRD from birth increased from 3.5% in 2000 to 4.0% in 2013 in males and decreased from 3.0% to 2.8% in females.

Limitations: Standard life-time assumption of fixed age-specific rates over time and possible ESRD misclassification. To be useful in clinical practice, this application will require additional predictors (eg, comorbid conditions and chronic kidney disease stage).

Conclusions: ESRD risk in the United States varies more than 2-fold among racial/ethnic groups for both sexes.

Keywords: End-stage renal disease (ESRD); US Renal Data System (USRDS); cumulative incidence; epidemiology; health inequity; incidence; lifetable; lifetime risk; mortality; nationwide surveillance; public health; racial disparity; risk; risk estimate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence rate (per million/year) of ESRD in the total US population, by age, sex, and the calendar period from which data were obtained
Figure 2
Figure 2
Mortality rate (per thousand/year) in non-ESRD persons in the total US population, by age, sex, and the calendar period from which data were obtained
Figure 3
Figure 3
Cumulative incidence (%) of ESRD from birth to age 100+, by race/ethnicity, in the US male population; based on data in 2013
Figure 4
Figure 4
Cumulative incidence (%) of ESRD from birth to age 100+, by race/ethnicity, in the US female population; based on data in 2013
Figure 5
Figure 5
Cumulative incidence (%) of ESRD from birth to age 100+, by method of estimation, in the total US population; based on data in 2013.
Figure 6
Figure 6
Cumulative incidence (%) of ESRD from birth to age 100+ in the total US population, by sex and the calendar period from which data were obtained
See this image and copyright information in PMC

Comment in

References

    1. United States Renal Data System . 2014 annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD:
    1. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM. White/black racial differences in risk of end-stage renal disease and death. Am J Med. 2009;122(7):672–678. - PMC - PubMed
    1. Morgenstern H, Kleinbaum DG, Kupper LL. Measures of disease incidence used in epidemiologic research. Int J Epidemiol. 1980;9(1):97–104. - PubMed
    1. Gail MH. Applications of personalized estimates of absolute breast cancer risk. Stat Biosci. 2013;5(2):303–315.
    1. Merrill RM, Kessler LG, Udler JM, Rasband GC, Feuer EJ. Comparison of risk estimates for selected diseases and causes of death. Prev Med. 1999;28(2):179–193. - PubMed

Publication types